Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Short

Showing results (421-430 of 659) with videos related to

Pageof 66
Sort By:
Blood|May 29, 2016
Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaNicholas J Short, Elias Jabbour, Koji Sasaki, et al.
Bone|June 23, 2004
Bone biomechanical properties in LRP5 mutant miceM P Akhter, D J Wells, S J Short, et al.
Leukemia & Lymphoma|February 2, 2026
Case series: rhabdomyolysis in patients taking isocitrate dehydrogenase inhibitors for myelodysplastic syndrome and relapsed/refractory acute myeloid leukemiaJacob E Herstein, Kayleigh R Marx, Fadi G Haddad, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 22, 2025
Tyrosine Kinase Inhibitors During Frontline Therapy in Adults With Acute Lymphoblastic Leukemia With ABL-class RearrangementsJulie Braish, Hagop Kantarjian, Nicholas J Short, et al.
Archives of Pathology & Laboratory Medicine|June 16, 2025
Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient CohortSa A Wang, Shaoying Li, Wei Wang, et al.
Leukemia & Lymphoma|August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remissionSamuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
American Journal of Hematology|May 28, 2022
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemiaShilpa Paul, Hagop Kantarjian, Koji Sasaki, et al.
American Journal of Hematology|March 7, 2019
NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated acute myeloid leukemiaHussein A Abbas, Farhad Ravandi, Sanam Loghavi, et al.
Leukemia|October 19, 2022
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysisNicholas J Short, Chenqi Fu, Donald A Berry, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 12, 2012
Concurrent resistance and aerobic exercise stimulates both myofibrillar and mitochondrial protein synthesis in sedentary middle-aged menCheyne E Donges, Nicholas A Burd, Rob Duffield, et al.
Pageof 66

Showing results (421-430 of 659) with videos related to

Sort By:
Pageof 66
Blood|May 29, 2016
Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaNicholas J Short, Elias Jabbour, Koji Sasaki, et al.
Bone|June 23, 2004
Bone biomechanical properties in LRP5 mutant miceM P Akhter, D J Wells, S J Short, et al.
Leukemia & Lymphoma|February 2, 2026
Case series: rhabdomyolysis in patients taking isocitrate dehydrogenase inhibitors for myelodysplastic syndrome and relapsed/refractory acute myeloid leukemiaJacob E Herstein, Kayleigh R Marx, Fadi G Haddad, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 22, 2025
Tyrosine Kinase Inhibitors During Frontline Therapy in Adults With Acute Lymphoblastic Leukemia With ABL-class RearrangementsJulie Braish, Hagop Kantarjian, Nicholas J Short, et al.
Archives of Pathology & Laboratory Medicine|June 16, 2025
Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient CohortSa A Wang, Shaoying Li, Wei Wang, et al.
Leukemia & Lymphoma|August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remissionSamuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
American Journal of Hematology|May 28, 2022
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemiaShilpa Paul, Hagop Kantarjian, Koji Sasaki, et al.
American Journal of Hematology|March 7, 2019
NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated acute myeloid leukemiaHussein A Abbas, Farhad Ravandi, Sanam Loghavi, et al.
Leukemia|October 19, 2022
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysisNicholas J Short, Chenqi Fu, Donald A Berry, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 12, 2012
Concurrent resistance and aerobic exercise stimulates both myofibrillar and mitochondrial protein synthesis in sedentary middle-aged menCheyne E Donges, Nicholas A Burd, Rob Duffield, et al.
Pageof 66